HK1225624A1 - 口腔可分散膜 - Google Patents

口腔可分散膜 Download PDF

Info

Publication number
HK1225624A1
HK1225624A1 HK16113913.9A HK16113913A HK1225624A1 HK 1225624 A1 HK1225624 A1 HK 1225624A1 HK 16113913 A HK16113913 A HK 16113913A HK 1225624 A1 HK1225624 A1 HK 1225624A1
Authority
HK
Hong Kong
Prior art keywords
oral dispersible
dispersible films
films
oral
disintegrant
Prior art date
Application number
HK16113913.9A
Other languages
English (en)
Chinese (zh)
Inventor
Ana Filipa SILVA BORGES
Branca Margarida ALMEIDA SILVA
Jorge Fernando JORDÃO COELHO
Cláudia SOUSA SILVA
Sérgio Paulo SIMÕES
Original Assignee
Bluepharma - Industria Farmaceutica, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bluepharma - Industria Farmaceutica, S.A. filed Critical Bluepharma - Industria Farmaceutica, S.A.
Publication of HK1225624A1 publication Critical patent/HK1225624A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
HK16113913.9A 2013-07-31 2014-07-31 口腔可分散膜 HK1225624A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361860516P 2013-07-31 2013-07-31
US61/860,516 2013-07-31

Publications (1)

Publication Number Publication Date
HK1225624A1 true HK1225624A1 (zh) 2017-09-15

Family

ID=51535496

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16113913.9A HK1225624A1 (zh) 2013-07-31 2014-07-31 口腔可分散膜

Country Status (8)

Country Link
US (1) US9603935B2 (enExample)
EP (1) EP3027172B1 (enExample)
JP (1) JP6294479B2 (enExample)
CN (1) CN105682639B (enExample)
BR (1) BR112016002205A2 (enExample)
ES (1) ES2835258T3 (enExample)
HK (1) HK1225624A1 (enExample)
WO (1) WO2015016727A2 (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
CN107106512A (zh) * 2015-11-25 2017-08-29 缇碧艾姆株式会社 口腔止血及伤口保护膜
US12239706B2 (en) 2015-11-30 2025-03-04 Seed Health, Inc. Method and system for protecting monarch butterflies from pesticides
PL3442537T3 (pl) * 2016-04-14 2024-07-15 Sensorion (+)-azasetron do zastosowania w leczeniu zaburzeń ucha
CN106619577A (zh) * 2016-10-08 2017-05-10 中国药科大学 一种新型氯雷他定口腔速溶膜及其制备方法
US10952959B2 (en) 2017-01-11 2021-03-23 Ferring B.V. Fast disintegrating pharmaceutical composition
US11154585B2 (en) * 2017-01-18 2021-10-26 Pharmathen S.A. Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population
US12472144B2 (en) 2017-08-08 2025-11-18 Amneal Pharmaceuticals Llc Pharmaceutical composition comprising eliglustat
WO2019030645A1 (en) 2017-08-08 2019-02-14 Kashiv Pharma Llc Pharmaceutical composition comprising eliglustat
US12150967B2 (en) 2018-08-18 2024-11-26 Seed Health, Inc. Methods and compositions for honey bee health
US11185526B2 (en) * 2018-09-04 2021-11-30 Babak Ghalili Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods
US11235013B2 (en) * 2018-09-04 2022-02-01 Babak Ghalili Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods
CN108785289A (zh) * 2018-09-06 2018-11-13 北京太阳升高科医药研究股份有限公司 盐酸那拉曲坦口溶膜剂及其制备方法
WO2020061584A1 (en) * 2018-09-21 2020-03-26 Msb Holdings, Inc. Taste-masked dosage forms
CN111166730A (zh) * 2018-11-13 2020-05-19 杨守忠 盐酸金刚烷胺的速释口溶膜及其制备方法和应用
IT201800020185A1 (it) * 2018-12-19 2020-06-19 Davide Fiumi Formulazioni contenenti vitamina d3 in film edibile per il trattamento di pazienti affetti da malassorbimento
CN109793201B (zh) * 2019-03-26 2022-08-09 武汉轻工大学 一种天然复合甜味剂及其制备方法和新型挤压面筋
CN112569208B (zh) * 2019-09-29 2023-10-31 四川科伦药物研究院有限公司 一种盐酸普拉克索药物组合物及其制备方法
US20210187858A1 (en) * 2019-12-18 2021-06-24 Dieu Cam Vuong Method and system for manufacturing of pharmaceutical formulas in form of orally disintegrating films (odf)
MX2022012499A (es) 2020-04-07 2022-12-15 Church & Dwight Co Inc Composicion detergente de lavanderia.
CN111388455B (zh) * 2020-04-09 2022-09-02 沈阳药科大学 一种依维莫司口腔膜剂及其制备方法
US20230330036A1 (en) * 2022-04-13 2023-10-19 Oak Therapeutics, Inc. Long acting, continuous oral release from oral dispersing strips (ods) addressing the need for high dosage of active ingredients
US12109303B2 (en) 2022-04-18 2024-10-08 ISHA Therapeutics LLC Orally dissolving antimicrobial film compositions and methods of their use
US20250108001A1 (en) * 2022-05-21 2025-04-03 Neuvision Development Llc Topical ocular administration of ambroxol for ocular pain
CN114886877B (zh) * 2022-06-16 2024-02-02 北京海泰天正医药科技有限公司 奥氮平氟西汀复方口溶膜及其制备方法
CN114983984B (zh) * 2022-07-26 2023-09-01 山东达因海洋生物制药股份有限公司 一种用于哮喘治疗复方口溶膜剂及其制备方法
CN118045064B (zh) * 2022-11-16 2025-08-26 上海云晟研新生物科技有限公司 一种地氯雷他定口溶膜组合物、其制备方法及应用
WO2024224405A1 (en) * 2023-04-28 2024-10-31 Lucky 4U Exims Oral dispersible film of mitragynine
GB2629820A (en) 2023-05-11 2024-11-13 Fitabeo Therapeutics Ltd Oral thin film formulations
CN119424384A (zh) * 2023-08-03 2025-02-14 上海云晟研新生物科技有限公司 普拉克索口溶膜组合物、其制备方法及应用
CN118236356B (zh) * 2024-05-28 2024-08-16 山东则正医药技术有限公司 一种特立氟胺口溶膜及其制备方法、应用和药物组合物
CN118252821B (zh) * 2024-05-28 2024-08-13 山东则正医药技术有限公司 与片剂生物等效的特立氟胺口溶膜及其制备方法和应用
CN118453550A (zh) * 2024-06-13 2024-08-09 上海欣峰制药有限公司 一种昂丹司琼口溶膜剂及其制备方法
CN119139272A (zh) * 2024-09-02 2024-12-17 华中药业股份有限公司 一种艾司唑仑口腔速溶膜剂及其制备方法
CN120324355B (zh) * 2025-06-16 2025-08-26 山东第一医科大学附属省立医院(山东省立医院) 一种依托考昔口崩片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2656338B2 (ja) * 1989-01-31 1997-09-24 日東電工株式会社 口腔粘膜貼付製剤
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
EP1458367B2 (en) * 2001-10-12 2021-01-27 Aquestive Therapeutics, Inc. Uniform films for rapidly dissolving dosage form incorporating taste-masking compositions
ES2735512T3 (es) * 2001-10-12 2019-12-19 Aquestive Therapeutics Inc Película delgada con heterogeneidad uniforme no autoagregable, proceso para su producción y sistemas de administración de fármacos hechos a partir de la misma
RU2005129309A (ru) 2003-05-02 2006-05-10 Уорнер-Ламберт Компани Эл-Эл-Си (US) Пригодные для перорального употребления быстрорастворимые пленки, содержащие модифицированный крахмал для улучшенной тепло-и влагоустойчивости
CA2689594A1 (en) * 2007-06-07 2008-12-11 Sato Pharmaceutical Co., Ltd. Film preparation with rapidly dissolving property and flexibility
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
CA2784587A1 (en) * 2009-12-28 2011-07-28 Monosol Rx, Llc Orally administrable film dosage forms containing ondansetron
CN103260592A (zh) * 2010-12-23 2013-08-21 高露洁-棕榄公司 膜和包含所述膜的组合物

Also Published As

Publication number Publication date
BR112016002205A2 (pt) 2017-08-01
US20150038594A1 (en) 2015-02-05
JP2016525572A (ja) 2016-08-25
EP3027172A2 (en) 2016-06-08
US9603935B2 (en) 2017-03-28
WO2015016727A4 (en) 2015-06-04
JP6294479B2 (ja) 2018-03-14
ES2835258T3 (es) 2021-06-22
CN105682639B (zh) 2021-02-05
CN105682639A (zh) 2016-06-15
WO2015016727A2 (en) 2015-02-05
WO2015016727A3 (en) 2015-04-16
EP3027172B1 (en) 2020-09-16

Similar Documents

Publication Publication Date Title
HK1225624A1 (zh) 口腔可分散膜
EP3199560A4 (en) Modified polyvinyl alcohol and water-soluble film
EP3246685A4 (en) Pressure-sensitive element, pressure sensor, and method for manufacturing pressure-sensitive element
EP3272387A4 (en) Drug administration device, and manufacturing method for drug administration device
EP3228654A4 (en) Gas barrier polymer, gas barrier film, and gas barrier laminate
EP3228646A4 (en) Polymer and polymer electrolyte membrane comprising same
EP3407804A4 (en) SYSTEMS AND METHOD FOR THE ADMINISTRATION OF A GASTROINTESTINAL IMPLANT
AU2015245230B2 (en) Polymeric rule die, and formulations therefor
EP3331583B8 (en) Medical implant based on nanocellulose
EP3270192A4 (en) Hydrophilic single-layer film having optical functionality, and laminate thereof
EP3348598A4 (en) Polyimide-based block copolymer and polyimide-based film comprising same
EP3216817A4 (en) Polymer film and adhesion-preventive material including same
EP3176284A4 (en) Laminate body and manufacturing method thereof, and gas barrier film and manufacturing method thereof
EP3109604A3 (en) Integrated active fuel characteristic sensor
EP3575343A4 (en) POLYIMIDE-BASED COPOLYMER AND POLYIMIDE-BASED FILM THEREFOR
EP3228642A4 (en) Polymer, method for manufacturing same, and electrolyte membrane comprising same
EP3534909A4 (en) POLYMANANOPARTICLE
IL282964A (en) Graphene polymer nanocomposite membrane assembly, and its production method
EP3205688A4 (en) Amphiphilic polymer
EP3268074A4 (en) Bite proof endotracheal tube
EP3181618A4 (en) Polymer functional film, stack or device provided with polymer functional film, and method of producing polymer functional film
EP3268425A4 (en) A polymer nanocomposite, process and applications thereof
EP3181619A4 (en) Polymer functional film, production method thereof, and stack or device provided with polymer functional film
EP3260045A4 (en) Apnea detection device
EP3222652A4 (en) Amphiphilic polymer